img

Global Mucopolysaccharidosis II Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Mucopolysaccharidosis II Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Mucopolysaccharidosis II report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Mucopolysaccharidosis II market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Mucopolysaccharidosis II industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Mucopolysaccharidosis II key manufacturers include Alexion Pharmaceuticals, Inc., AngioChem Inc., ArmaGen Inc., Bioasis Technologies Inc., Green Cross Corporation, Inventiva, JCR Pharmaceuticals Co., Ltd., Laboratorios Del Dr. Esteve S.A. and RegenxBio Inc., etc. Alexion Pharmaceuticals, Inc., AngioChem Inc., ArmaGen Inc. are top 3 players and held % sales share in total in 2022.
Mucopolysaccharidosis II can be divided into JR-141, EGT-301, DUOC-01 and AGT-182, etc. JR-141 is the mainstream product in the market, accounting for % sales share globally in 2022.
Mucopolysaccharidosis II is widely used in various fields, such as Hospital, Clinic, Research Center and Others, etc. Hospital provides greatest supports to the Mucopolysaccharidosis II industry development. In 2022, global % sales of Mucopolysaccharidosis II went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Mucopolysaccharidosis II market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Alexion Pharmaceuticals, Inc.
AngioChem Inc.
ArmaGen Inc.
Bioasis Technologies Inc.
Green Cross Corporation
Inventiva
JCR Pharmaceuticals Co., Ltd.
Laboratorios Del Dr. Esteve S.A.
RegenxBio Inc.
Sangamo BioSciences, Inc.
Takeda
Segment by Type
JR-141
EGT-301
DUOC-01
AGT-182
JR-032
Others

Segment by Application


Hospital
Clinic
Research Center
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Mucopolysaccharidosis II market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Mucopolysaccharidosis II, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Mucopolysaccharidosis II industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Mucopolysaccharidosis II in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Mucopolysaccharidosis II introduction, etc. Mucopolysaccharidosis II Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Mucopolysaccharidosis II market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Mucopolysaccharidosis II Market Overview
1.1 Mucopolysaccharidosis II Product Overview
1.2 Mucopolysaccharidosis II Market Segment by Type
1.2.1 JR-141
1.2.2 EGT-301
1.2.3 DUOC-01
1.2.4 AGT-182
1.2.5 JR-032
1.2.6 Others
1.3 Global Mucopolysaccharidosis II Market Size by Type
1.3.1 Global Mucopolysaccharidosis II Market Size Overview by Type (2018-2034)
1.3.2 Global Mucopolysaccharidosis II Historic Market Size Review by Type (2018-2024)
1.3.3 Global Mucopolysaccharidosis II Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Mucopolysaccharidosis II Sales Breakdown by Type (2018-2024)
1.4.2 Europe Mucopolysaccharidosis II Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Mucopolysaccharidosis II Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Mucopolysaccharidosis II Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Mucopolysaccharidosis II Sales Breakdown by Type (2018-2024)
2 Global Mucopolysaccharidosis II Market Competition by Company
2.1 Global Top Players by Mucopolysaccharidosis II Sales (2018-2024)
2.2 Global Top Players by Mucopolysaccharidosis II Revenue (2018-2024)
2.3 Global Top Players by Mucopolysaccharidosis II Price (2018-2024)
2.4 Global Top Manufacturers Mucopolysaccharidosis II Manufacturing Base Distribution, Sales Area, Product Type
2.5 Mucopolysaccharidosis II Market Competitive Situation and Trends
2.5.1 Mucopolysaccharidosis II Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Mucopolysaccharidosis II Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mucopolysaccharidosis II as of 2022)
2.7 Date of Key Manufacturers Enter into Mucopolysaccharidosis II Market
2.8 Key Manufacturers Mucopolysaccharidosis II Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Mucopolysaccharidosis II Status and Outlook by Region
3.1 Global Mucopolysaccharidosis II Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Mucopolysaccharidosis II Historic Market Size by Region
3.2.1 Global Mucopolysaccharidosis II Sales in Volume by Region (2018-2024)
3.2.2 Global Mucopolysaccharidosis II Sales in Value by Region (2018-2024)
3.2.3 Global Mucopolysaccharidosis II Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Mucopolysaccharidosis II Forecasted Market Size by Region
3.3.1 Global Mucopolysaccharidosis II Sales in Volume by Region (2024-2034)
3.3.2 Global Mucopolysaccharidosis II Sales in Value by Region (2024-2034)
3.3.3 Global Mucopolysaccharidosis II Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Mucopolysaccharidosis II by Application
4.1 Mucopolysaccharidosis II Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Research Center
4.1.4 Others
4.2 Global Mucopolysaccharidosis II Market Size by Application
4.2.1 Global Mucopolysaccharidosis II Market Size Overview by Application (2018-2034)
4.2.2 Global Mucopolysaccharidosis II Historic Market Size Review by Application (2018-2024)
4.2.3 Global Mucopolysaccharidosis II Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Mucopolysaccharidosis II Sales Breakdown by Application (2018-2024)
4.3.2 Europe Mucopolysaccharidosis II Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Mucopolysaccharidosis II Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Mucopolysaccharidosis II Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Mucopolysaccharidosis II Sales Breakdown by Application (2018-2024)
5 North America Mucopolysaccharidosis II by Country
5.1 North America Mucopolysaccharidosis II Historic Market Size by Country
5.1.1 North America Mucopolysaccharidosis II Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Mucopolysaccharidosis II Sales in Volume by Country (2018-2024)
5.1.3 North America Mucopolysaccharidosis II Sales in Value by Country (2018-2024)
5.2 North America Mucopolysaccharidosis II Forecasted Market Size by Country
5.2.1 North America Mucopolysaccharidosis II Sales in Volume by Country (2024-2034)
5.2.2 North America Mucopolysaccharidosis II Sales in Value by Country (2024-2034)
6 Europe Mucopolysaccharidosis II by Country
6.1 Europe Mucopolysaccharidosis II Historic Market Size by Country
6.1.1 Europe Mucopolysaccharidosis II Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Mucopolysaccharidosis II Sales in Volume by Country (2018-2024)
6.1.3 Europe Mucopolysaccharidosis II Sales in Value by Country (2018-2024)
6.2 Europe Mucopolysaccharidosis II Forecasted Market Size by Country
6.2.1 Europe Mucopolysaccharidosis II Sales in Volume by Country (2024-2034)
6.2.2 Europe Mucopolysaccharidosis II Sales in Value by Country (2024-2034)
7 Asia-Pacific Mucopolysaccharidosis II by Region
7.1 Asia-Pacific Mucopolysaccharidosis II Historic Market Size by Region
7.1.1 Asia-Pacific Mucopolysaccharidosis II Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Mucopolysaccharidosis II Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Mucopolysaccharidosis II Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Mucopolysaccharidosis II Forecasted Market Size by Region
7.2.1 Asia-Pacific Mucopolysaccharidosis II Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Mucopolysaccharidosis II Sales in Value by Region (2024-2034)
8 Latin America Mucopolysaccharidosis II by Country
8.1 Latin America Mucopolysaccharidosis II Historic Market Size by Country
8.1.1 Latin America Mucopolysaccharidosis II Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Mucopolysaccharidosis II Sales in Volume by Country (2018-2024)
8.1.3 Latin America Mucopolysaccharidosis II Sales in Value by Country (2018-2024)
8.2 Latin America Mucopolysaccharidosis II Forecasted Market Size by Country
8.2.1 Latin America Mucopolysaccharidosis II Sales in Volume by Country (2024-2034)
8.2.2 Latin America Mucopolysaccharidosis II Sales in Value by Country (2024-2034)
9 Middle East and Africa Mucopolysaccharidosis II by Country
9.1 Middle East and Africa Mucopolysaccharidosis II Historic Market Size by Country
9.1.1 Middle East and Africa Mucopolysaccharidosis II Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Mucopolysaccharidosis II Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Mucopolysaccharidosis II Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Mucopolysaccharidosis II Forecasted Market Size by Country
9.2.1 Middle East and Africa Mucopolysaccharidosis II Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Mucopolysaccharidosis II Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Alexion Pharmaceuticals, Inc.
10.1.1 Alexion Pharmaceuticals, Inc. Company Information
10.1.2 Alexion Pharmaceuticals, Inc. Introduction and Business Overview
10.1.3 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Products Offered
10.1.5 Alexion Pharmaceuticals, Inc. Recent Development
10.2 AngioChem Inc.
10.2.1 AngioChem Inc. Company Information
10.2.2 AngioChem Inc. Introduction and Business Overview
10.2.3 AngioChem Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2024)
10.2.4 AngioChem Inc. Mucopolysaccharidosis II Products Offered
10.2.5 AngioChem Inc. Recent Development
10.3 ArmaGen Inc.
10.3.1 ArmaGen Inc. Company Information
10.3.2 ArmaGen Inc. Introduction and Business Overview
10.3.3 ArmaGen Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2024)
10.3.4 ArmaGen Inc. Mucopolysaccharidosis II Products Offered
10.3.5 ArmaGen Inc. Recent Development
10.4 Bioasis Technologies Inc.
10.4.1 Bioasis Technologies Inc. Company Information
10.4.2 Bioasis Technologies Inc. Introduction and Business Overview
10.4.3 Bioasis Technologies Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Bioasis Technologies Inc. Mucopolysaccharidosis II Products Offered
10.4.5 Bioasis Technologies Inc. Recent Development
10.5 Green Cross Corporation
10.5.1 Green Cross Corporation Company Information
10.5.2 Green Cross Corporation Introduction and Business Overview
10.5.3 Green Cross Corporation Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Green Cross Corporation Mucopolysaccharidosis II Products Offered
10.5.5 Green Cross Corporation Recent Development
10.6 Inventiva
10.6.1 Inventiva Company Information
10.6.2 Inventiva Introduction and Business Overview
10.6.3 Inventiva Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Inventiva Mucopolysaccharidosis II Products Offered
10.6.5 Inventiva Recent Development
10.7 JCR Pharmaceuticals Co., Ltd.
10.7.1 JCR Pharmaceuticals Co., Ltd. Company Information
10.7.2 JCR Pharmaceuticals Co., Ltd. Introduction and Business Overview
10.7.3 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2024)
10.7.4 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Products Offered
10.7.5 JCR Pharmaceuticals Co., Ltd. Recent Development
10.8 Laboratorios Del Dr. Esteve S.A.
10.8.1 Laboratorios Del Dr. Esteve S.A. Company Information
10.8.2 Laboratorios Del Dr. Esteve S.A. Introduction and Business Overview
10.8.3 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Products Offered
10.8.5 Laboratorios Del Dr. Esteve S.A. Recent Development
10.9 RegenxBio Inc.
10.9.1 RegenxBio Inc. Company Information
10.9.2 RegenxBio Inc. Introduction and Business Overview
10.9.3 RegenxBio Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2024)
10.9.4 RegenxBio Inc. Mucopolysaccharidosis II Products Offered
10.9.5 RegenxBio Inc. Recent Development
10.10 Sangamo BioSciences, Inc.
10.10.1 Sangamo BioSciences, Inc. Company Information
10.10.2 Sangamo BioSciences, Inc. Introduction and Business Overview
10.10.3 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Products Offered
10.10.5 Sangamo BioSciences, Inc. Recent Development
10.11 Takeda
10.11.1 Takeda Company Information
10.11.2 Takeda Introduction and Business Overview
10.11.3 Takeda Mucopolysaccharidosis II Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Takeda Mucopolysaccharidosis II Products Offered
10.11.5 Takeda Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Mucopolysaccharidosis II Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Mucopolysaccharidosis II Industrial Chain Analysis
11.4 Mucopolysaccharidosis II Market Dynamics
11.4.1 Mucopolysaccharidosis II Industry Trends
11.4.2 Mucopolysaccharidosis II Market Drivers
11.4.3 Mucopolysaccharidosis II Market Challenges
11.4.4 Mucopolysaccharidosis II Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Mucopolysaccharidosis II Distributors
12.3 Mucopolysaccharidosis II Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of JR-141
Table 2. Major Company of EGT-301
Table 3. Major Company of DUOC-01
Table 4. Major Company of AGT-182
Table 5. Major Company of JR-032
Table 6. Major Company of Others
Table 7. Global Mucopolysaccharidosis II Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Mucopolysaccharidosis II Sales by Type (2018-2024) & (K Pcs)
Table 9. Global Mucopolysaccharidosis II Sales Market Share in Volume by Type (2018-2024)
Table 10. Global Mucopolysaccharidosis II Sales by Type (2018-2024) & (US& Million)
Table 11. Global Mucopolysaccharidosis II Market Share in Value by Type (2018-2024)
Table 12. Global Mucopolysaccharidosis II Price by Type (2018-2024) & (USD/Pcs)
Table 13. Global Mucopolysaccharidosis II Sales by Type (2024-2034) & (K Pcs)
Table 14. Global Mucopolysaccharidosis II Sales Market Share in Volume by Type (2024-2034)
Table 15. Global Mucopolysaccharidosis II Sales by Type (2024-2034) & (US$ Million)
Table 16. Global Mucopolysaccharidosis II Sales Market Share in Value by Type (2024-2034)
Table 17. Global Mucopolysaccharidosis II Price by Type (2024-2034) & (USD/Pcs)
Table 18. North America Mucopolysaccharidosis II Sales by Type (2018-2024) & (K Pcs)
Table 19. North America Mucopolysaccharidosis II Sales by Type (2018-2024) & (US$ Million)
Table 20. Europe Mucopolysaccharidosis II Sales (K Pcs) by Type (2018-2024)
Table 21. Europe Mucopolysaccharidosis II Sales by Type (2018-2024) & (US$ Million)
Table 22. Asia-Pacific Mucopolysaccharidosis II Sales (K Pcs) by Type (2018-2024)
Table 23. Asia-Pacific Mucopolysaccharidosis II Sales by Type (2018-2024) & (US$ Million)
Table 24. Latin America Mucopolysaccharidosis II Sales (K Pcs) by Type (2018-2024)
Table 25. Latin America Mucopolysaccharidosis II Sales by Type (2018-2024) & (US$ Million)
Table 26. Middle East and Africa Mucopolysaccharidosis II Sales (K Pcs) by Type (2018-2024)
Table 27. Middle East and Africa Mucopolysaccharidosis II Sales by Type (2018-2024) & (US$ Million)
Table 28. Global Mucopolysaccharidosis II Sales by Company (2018-2024) & (K Pcs)
Table 29. Global Mucopolysaccharidosis II Sales Share by Company (2018-2024)
Table 30. Global Mucopolysaccharidosis II Revenue by Company (2018-2024) & (US$ Million)
Table 31. Global Mucopolysaccharidosis II Revenue Share by Company (2018-2024)
Table 32. Global Market Mucopolysaccharidosis II Price by Company (2018-2024) & (USD/Pcs)
Table 33. Global Mucopolysaccharidosis II Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global Mucopolysaccharidosis II Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mucopolysaccharidosis II as of 2022)
Table 36. Date of Key Manufacturers Enter into Mucopolysaccharidosis II Market
Table 37. Key Manufacturers Mucopolysaccharidosis II Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Mucopolysaccharidosis II Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 40. Global Mucopolysaccharidosis II Sales by Region (2018-2024) & (K Pcs)
Table 41. Global Mucopolysaccharidosis II Sales Market Share in Volume by Region (2018-2024)
Table 42. Global Mucopolysaccharidosis II Sales by Region (2018-2024) & (US$ Million)
Table 43. Global Mucopolysaccharidosis II Sales Market Share in Value by Region (2018-2024)
Table 44. Global Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 45. Global Mucopolysaccharidosis II Sales by Region (2024-2034) & (K Pcs)
Table 46. Global Mucopolysaccharidosis II Sales Market Share in Volume by Region (2024-2034)
Table 47. Global Mucopolysaccharidosis II Sales by Region (2024-2034) & (US$ Million)
Table 48. Global Mucopolysaccharidosis II Sales Market Share in Value by Region (2024-2034)
Table 49. Global Mucopolysaccharidosis II Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 50. Global Mucopolysaccharidosis II Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 51. Global Mucopolysaccharidosis II Sales by Application (2018-2024) & (K Pcs)
Table 52. Global Mucopolysaccharidosis II Sales Market Share in Volume by Application (2018-2024)
Table 53. Global Mucopolysaccharidosis II Sales by Application (2018-2024) & (US$ Million)
Table 54. Global Mucopolysaccharidosis II Sales Market Share in Value by Application (2018-2024)
Table 55. Global Mucopolysaccharidosis II Price by Application (2018-2024) & (USD/Pcs)
Table 56. Global Mucopolysaccharidosis II Sales by Application (2024-2034) & (K Pcs)
Table 57. Global Mucopolysaccharidosis II Sales Market Share in Volume by Application (2024-2034)
Table 58. Global Mucopolysaccharidosis II Sales by Application (2024-2034) & (US$ Million)
Table 59. Global Mucopolysaccharidosis II Sales Market Share in Value by Application (2024-2034)
Table 60. Global Mucopolysaccharidosis II Price by Application (2024-2034) & (USD/Pcs)
Table 61. North America Mucopolysaccharidosis II Sales by Application (2018-2024) (K Pcs)
Table 62. North America Mucopolysaccharidosis II Sales by Application (2018-2024) & (US$ Million)
Table 63. Europe Mucopolysaccharidosis II Sales by Application (2018-2024) (K Pcs)
Table 64. Europe Mucopolysaccharidosis II Sales by Application (2018-2024) & (US$ Million)
Table 65. Asia-Pacific Mucopolysaccharidosis II Sales by Application (2018-2024) (K Pcs)
Table 66. Asia-Pacific Mucopolysaccharidosis II Sales by Application (2018-2024) & (US$ Million)
Table 67. Latin America Mucopolysaccharidosis II Sales by Application (2018-2024) (K Pcs)
Table 68. Latin America Mucopolysaccharidosis II Sales by Application (2018-2024) & (US$ Million)
Table 69. Middle East and Africa Mucopolysaccharidosis II Sales by Application (2018-2024) (K Pcs)
Table 70. Middle East and Africa Mucopolysaccharidosis II Sales by Application (2018-2024) & (US$ Million)
Table 71. North America Mucopolysaccharidosis II Sales by Country (2018-2024) & (K Pcs)
Table 72. North America Mucopolysaccharidosis II Sales Market Share in Volume by Country (2018-2024)
Table 73. North America Mucopolysaccharidosis II Sales by Country (2018-2024) & (US$ Million)
Table 74. North America Mucopolysaccharidosis II Sales Market Share in Value by Country (2018-2024)
Table 75. North America Mucopolysaccharidosis II Sales by Country (2024-2034) & (K Pcs)
Table 76. North America Mucopolysaccharidosis II Sales Market Share in Volume by Country (2024-2034)
Table 77. North America Mucopolysaccharidosis II Sales by Country (2024-2034) & (US$ Million)
Table 78. North America Mucopolysaccharidosis II Sales Market Share in Value by Country (2024-2034)
Table 79. Europe Mucopolysaccharidosis II Sales by Country (2018-2024) & (K Pcs)
Table 80. Europe Mucopolysaccharidosis II Sales Market Share in Volume by Country (2018-2024)
Table 81. Europe Mucopolysaccharidosis II Sales by Country (2018-2024) & (US$ Million)
Table 82. Europe Mucopolysaccharidosis II Sales Market Share in Value by Country (2018-2024)
Table 83. Europe Mucopolysaccharidosis II Sales by Country (2024-2034) & (K Pcs)
Table 84. Europe Mucopolysaccharidosis II Sales Market Share in Volume by Country (2024-2034)
Table 85. Europe Mucopolysaccharidosis II Sales by Country (2024-2034) & (US$ Million)
Table 86. Europe Mucopolysaccharidosis II Sales Market Share in Value by Country (2024-2034)
Table 87. Asia-Pacific Mucopolysaccharidosis II Sales by Region (2018-2024) & (K Pcs)
Table 88. Asia-Pacific Mucopolysaccharidosis II Sales Market Share in Volume by Region (2018-2024)
Table 89. Asia-Pacific Mucopolysaccharidosis II Sales by Region (2018-2024) & (US$ Million)
Table 90. Asia-Pacific Mucopolysaccharidosis II Sales Market Share in Value by Region (2018-2024)
Table 91. Asia-Pacific Mucopolysaccharidosis II Sales by Region (2024-2034) & (K Pcs)
Table 92. Asia-Pacific Mucopolysaccharidosis II Sales Market Share in Volume by Region (2024-2034)
Table 93. Asia-Pacific Mucopolysaccharidosis II Sales by Region (2024-2034) & (US$ Million)
Table 94. Asia-Pacific Mucopolysaccharidosis II Sales Market Share in Value by Region (2024-2034)
Table 95. Latin America Mucopolysaccharidosis II Sales by Country (2018-2024) & (K Pcs)
Table 96. Latin America Mucopolysaccharidosis II Sales Market Share in Volume by Country (2018-2024)
Table 97. Latin America Mucopolysaccharidosis II Sales by Country (2018-2024) & (US$ Million)
Table 98. Latin America Mucopolysaccharidosis II Sales Market Share in Value by Country (2018-2024)
Table 99. Latin America Mucopolysaccharidosis II Sales by Country (2024-2034) & (K Pcs)
Table 100. Latin America Mucopolysaccharidosis II Sales Market Share in Volume by Country (2024-2034)
Table 101. Latin America Mucopolysaccharidosis II Sales by Country (2024-2034) & (US$ Million)
Table 102. Latin America Mucopolysaccharidosis II Sales Market Share in Value by Country (2024-2034)
Table 103. Middle East and Africa Mucopolysaccharidosis II Sales by Country (2018-2024) & (K Pcs)
Table 104. Middle East and Africa Mucopolysaccharidosis II Sales Market Share in Volume by Country (2018-2024)
Table 105. Middle East and Africa Mucopolysaccharidosis II Sales by Country (2018-2024) & (US$ Million)
Table 106. Middle East and Africa Mucopolysaccharidosis II Sales Market Share in Value by Country (2018-2024)
Table 107. Middle East and Africa Mucopolysaccharidosis II Sales by Country (2024-2034) & (K Pcs)
Table 108. Middle East and Africa Mucopolysaccharidosis II Sales Market Share in Volume by Country (2024-2034)
Table 109. Middle East and Africa Mucopolysaccharidosis II Sales by Country (2024-2034) & (US$ Million)
Table 110. Middle East and Africa Mucopolysaccharidosis II Sales Market Share in Value by Country (2024-2034)
Table 111. Alexion Pharmaceuticals, Inc. Company Information
Table 112. Alexion Pharmaceuticals, Inc. Introduction and Business Overview
Table 113. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 114. Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Product
Table 115. Alexion Pharmaceuticals, Inc. Recent Development
Table 116. AngioChem Inc. Company Information
Table 117. AngioChem Inc. Introduction and Business Overview
Table 118. AngioChem Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 119. AngioChem Inc. Mucopolysaccharidosis II Product
Table 120. AngioChem Inc. Recent Development
Table 121. ArmaGen Inc. Company Information
Table 122. ArmaGen Inc. Introduction and Business Overview
Table 123. ArmaGen Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 124. ArmaGen Inc. Mucopolysaccharidosis II Product
Table 125. ArmaGen Inc. Recent Development
Table 126. Bioasis Technologies Inc. Company Information
Table 127. Bioasis Technologies Inc. Introduction and Business Overview
Table 128. Bioasis Technologies Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 129. Bioasis Technologies Inc. Mucopolysaccharidosis II Product
Table 130. Bioasis Technologies Inc. Recent Development
Table 131. Green Cross Corporation Company Information
Table 132. Green Cross Corporation Introduction and Business Overview
Table 133. Green Cross Corporation Mucopolysaccharidosis II Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 134. Green Cross Corporation Mucopolysaccharidosis II Product
Table 135. Green Cross Corporation Recent Development
Table 136. Inventiva Company Information
Table 137. Inventiva Introduction and Business Overview
Table 138. Inventiva Mucopolysaccharidosis II Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 139. Inventiva Mucopolysaccharidosis II Product
Table 140. Inventiva Recent Development
Table 141. JCR Pharmaceuticals Co., Ltd. Company Information
Table 142. JCR Pharmaceuticals Co., Ltd. Introduction and Business Overview
Table 143. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 144. JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Product
Table 145. JCR Pharmaceuticals Co., Ltd. Recent Development
Table 146. Laboratorios Del Dr. Esteve S.A. Company Information
Table 147. Laboratorios Del Dr. Esteve S.A. Introduction and Business Overview
Table 148. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 149. Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Product
Table 150. Laboratorios Del Dr. Esteve S.A. Recent Development
Table 151. RegenxBio Inc. Company Information
Table 152. RegenxBio Inc. Introduction and Business Overview
Table 153. RegenxBio Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 154. RegenxBio Inc. Mucopolysaccharidosis II Product
Table 155. RegenxBio Inc. Recent Development
Table 156. Sangamo BioSciences, Inc. Company Information
Table 157. Sangamo BioSciences, Inc. Introduction and Business Overview
Table 158. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 159. Sangamo BioSciences, Inc. Mucopolysaccharidosis II Product
Table 160. Sangamo BioSciences, Inc. Recent Development
Table 161. Takeda Company Information
Table 162. Takeda Introduction and Business Overview
Table 163. Takeda Mucopolysaccharidosis II Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 164. Takeda Mucopolysaccharidosis II Product
Table 165. Takeda Recent Development
Table 166. Key Raw Materials Lists
Table 167. Raw Materials Key Suppliers Lists
Table 168. Mucopolysaccharidosis II Market Trends
Table 169. Mucopolysaccharidosis II Market Drivers
Table 170. Mucopolysaccharidosis II Market Challenges
Table 171. Mucopolysaccharidosis II Market Restraints
Table 172. Mucopolysaccharidosis II Distributors List
Table 173. Mucopolysaccharidosis II Downstream Customers
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Mucopolysaccharidosis II Product Picture
Figure 2. Global Mucopolysaccharidosis II Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Mucopolysaccharidosis II Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Mucopolysaccharidosis II Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of JR-141
Figure 6. Global JR-141 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of EGT-301
Figure 8. Global EGT-301 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of DUOC-01
Figure 10. Global DUOC-01 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of AGT-182
Figure 12. Global AGT-182 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of JR-032
Figure 14. Global JR-032 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Product Picture of Others
Figure 16. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 17. Global Mucopolysaccharidosis II Sales by Type (2018-2034) & (US$ Million)
Figure 18. Global Mucopolysaccharidosis II Sales Market Share by Type in 2022 & 2034
Figure 19. North America Mucopolysaccharidosis II Sales Market Share in Volume by Type in 2022
Figure 20. North America Mucopolysaccharidosis II Sales Market Share in Value by Type in 2022
Figure 21. Europe Mucopolysaccharidosis II Sales Market Share in Volume by Type in 2022
Figure 22. Europe Mucopolysaccharidosis II Sales Market Share in Value by Type in 2022
Figure 23. Asia-Pacific Mucopolysaccharidosis II Sales Market Share in Volume by Type in 2022
Figure 24. Asia-Pacific Mucopolysaccharidosis II Sales Market Share in Value by Type in 2022
Figure 25. Latin America Mucopolysaccharidosis II Sales Market Share in Volume by Type in 2022
Figure 26. Latin America Mucopolysaccharidosis II Sales Market Share in Value by Type in 2022
Figure 27. Middle East and Africa Mucopolysaccharidosis II Sales Market Share in Volume by Type in 2022
Figure 28. Middle East and Africa Mucopolysaccharidosis II Sales Market Share in Value by Type in 2022
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Mucopolysaccharidosis II Sales in 2022
Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Mucopolysaccharidosis II Revenue in 2022
Figure 31. Mucopolysaccharidosis II Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Product Picture of Hospital
Figure 33. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Clinic
Figure 35. Global Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Research Center
Figure 37. Global Research Center Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Product Picture of Others
Figure 39. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 40. Global Mucopolysaccharidosis II Sales by Application (2018-2034) & (US$ Million)
Figure 41. Global Mucopolysaccharidosis II Sales Market Share by Application in 2022 & 2034
Figure 42. North America Mucopolysaccharidosis II Sales Market Share in Volume by Application in 2022
Figure 43. North America Mucopolysaccharidosis II Sales Market Share in Value by Application in 2022
Figure 44. Europe Mucopolysaccharidosis II Sales Market Share in Volume by Application in 2022
Figure 45. Europe Mucopolysaccharidosis II Sales Market Share in Value by Application in 2022
Figure 46. Asia-Pacific Mucopolysaccharidosis II Sales Market Share in Volume by Application in 2022
Figure 47. Asia-Pacific Mucopolysaccharidosis II Sales Market Share in Value by Application in 2022
Figure 48. Latin America Mucopolysaccharidosis II Sales Market Share in Volume by Application in 2022
Figure 49. Latin America Mucopolysaccharidosis II Sales Market Share in Value by Application in 2022
Figure 50. Middle East and Africa Mucopolysaccharidosis II Sales Market Share in Value by Application in 2022
Figure 51. Key Raw Materials Price
Figure 52. Mucopolysaccharidosis II Manufacturing Cost Structure
Figure 53. Mucopolysaccharidosis II Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries